Harpoon Therapeutics Valuation
| HARPDelisted Stock | USD 0.85 0.00 0.00% |
Today, the firm appears to be overvalued. Harpoon Therapeutics retains a regular Real Value of $0.66 per share. The prevalent price of the firm is $0.85. Our model calculates the value of Harpoon Therapeutics from evaluating the firm fundamentals such as Return On Asset of -0.36, current valuation of 475.25 M, and Return On Equity of -2.84 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Harpoon Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Harpoon Therapeutics is based on 3 months time horizon. Increasing Harpoon Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Harpoon Therapeutics' intrinsic value may or may not be the same as its current market price of 0.85, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.85 | Real 0.66 | Hype 0.85 | Naive 0.82 |
The intrinsic value of Harpoon Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Harpoon Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Harpoon Therapeutics helps investors to forecast how Harpoon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Harpoon Therapeutics more accurately as focusing exclusively on Harpoon Therapeutics' fundamentals will not take into account other important factors: Harpoon Therapeutics Total Value Analysis
Harpoon Therapeutics is currently projected to have valuation of 475.25 M with market capitalization of 492.35 M, debt of 16.01 M, and cash on hands of 90.15 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Harpoon Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
475.25 M | 492.35 M | 16.01 M | 90.15 M |
Harpoon Therapeutics Investor Information
About 83.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 8.62. Harpoon Therapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 5th of September 2023. Based on the key indicators related to Harpoon Therapeutics' liquidity, profitability, solvency, and operating efficiency, Harpoon Therapeutics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Harpoon Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Harpoon Therapeutics has an asset utilization ratio of 50.65 percent. This connotes that the Company is making $0.51 for each dollar of assets. An increasing asset utilization means that Harpoon Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Harpoon Therapeutics Ownership Allocation
Harpoon Therapeutics has a total of 21.4 Million outstanding shares. The majority of Harpoon Therapeutics outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Harpoon Therapeutics to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Harpoon Therapeutics. Please pay attention to any change in the institutional holdings of Harpoon Therapeutics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Harpoon Therapeutics Profitability Analysis
The company reported the previous year's revenue of 37.34 M. Net Loss for the year was (30.5 M) with loss before overhead, payroll, taxes, and interest of (49.48 M).About Harpoon Therapeutics Valuation
The delisted stock valuation mechanism determines Harpoon Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Harpoon Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Harpoon Therapeutics. We calculate exposure to Harpoon Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Harpoon Therapeutics's related companies.Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the bodys immune system to treat patients suffering from cancer and other diseases in the United States. Harpoon Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Harpoon Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
Harpoon Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Harpoon Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 3.3 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Harpoon Stock
If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |